	Heterotopic prostatic tissue mimicking prostate cancer: the decisive role of multiparametric MRI. BMJ Case Rep Pedde M, Solinas E, Masala S, Scaglione M, Amadu AM. PMID: 42767790 [PubMed - indexed for MEDLINE]
	Phase 1 study of KHK2455, a long-acting, potent and selective IDO1 inhibitor, in combination with avelumab in patients with locally advanced or metastatic urothelial carcinoma. J Immunother Cancer Zakharia Y, de Spéville BD, Morales-Barrera R, Moreno I, Kilari D, Peguero J, Rao S, Shiue LH, Kanda H, Liu Y, Arora P, Vuppugalla R, Rodriguez-Vida A. PMID: 42767768 [PubMed - indexed for MEDLINE]
	Pre-diagnosis plasma cell-free DNA reveals early signatures of prostate and breast cancer risk up to eight years prior to clinical detection. Cell Genom Cheng N, Ouellette TW, Skead K, Singhawansa A, Elliott M, Cescon DW, Bratman SV, De Carvalho DD, Soave D, Awadalla P. PMID: 42767223 [PubMed - as supplied by publisher]
	Health-related quality of life with adjuvant immune checkpoint inhibition in renal cell carcinoma: A qualitative study of UK participants in the phase III RAMPART trial. PLoS One Merrick S, South A, Frangou E, Rush HL, Patel G, Thompson J, Plant H, Pickering L, Langley RE, Gilbert DC, Powles T, Larkin J, Meade A. PMID: 42766600 [PubMed - indexed for MEDLINE]
	Recent advances in hormone-based biopharmaceuticals for cancer therapy. J Egypt Natl Canc Inst Sarifulnazwan SN, Mohd Tajuddin NAF, Mohd Nasaruddin SNN, Muhammad Mukmin NMI, Engku Abdul Malik ESNS, Taher M, Susanti D, Khotib J, Faiyazuddin M, Widodo RT, Haris MS, Budiman H. PMID: 42766044 [PubMed - indexed for MEDLINE]
	Prognostic Stratification in High-Volume Metastatic Hormone-Sensitive Prostate Cancer Treated With First-Line Androgen Receptor Pathway Inhibitor-Based Combination Therapy. Int J Urol Miyajima K, Yanagisawa T, Fukuokaya W, Sakakibara R, Uchida N, Miszczyk M, Inoue S, Matsukawa A, Urabe F, Mori K, Fujita N, Narita S, Hatakeyama S, Habuchi T, Shariat SF, Kimura T, JHA Collaborative Group. PMID: 42765507 [PubMed - indexed for MEDLINE]
	Task-agnostic explainable contrastive learning model for malignant cell detection in urine cytology. Biomed Phys Eng Express N P AM, Iyer RS, N PP, B JP, Dey P. PMID: 42765133 [PubMed - indexed for MEDLINE]
	Emerging Patterns of Kidney Cancer in Young Adults: Where Do We Stand? Emerging Patterns of Kidney Cancer in Young Adults: Where Do We Stand? Crit Rev Oncol Hematol Troisi P, Occhipinti D, Ligato C, Sardaro V, Campi R, Merenda E, Cappoli N, Arduini D, Messina G, Di Leo D, Neri A, Rossi F, Moosavi SK, Russo P, Foschi N, Sighinolfi C, Pierconti F, Rocco B, Tortora G, Ciccarese C, Iacovelli R. PMID: 42764100 [PubMed - as supplied by publisher]
	Current Management and Investigational Therapeutic Strategies in Penile Squamous Cell Carcinoma: A Narrative Review. Crit Rev Oncol Hematol Lobianco L, Calvanese G, D'Alessio C, Passaro F, Passarelli A, Ventriglia J, Cecere SC, Rossetti S, Pisano C, Tambaro R, Napoli MD, Contieri R, Aveta A, Perri E, Pacifico G, Lamia MR, Coppola E, Tarotto L, Feroce F, Sepe F, Perasole G, Troiani T, Pignata S. PMID: 42764099 [PubMed - as supplied by publisher]
	Clinical Impact of Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA-PET) on Staging, Biochemical Recurrence Detection, and Treatment Decision-Making in Prostate Cancer. Cureus Aad S, Houmani R, Houmani J, Saad C, Sassounian H, Daouk L, Karam C, Houmani M. PMID: 42763717 [PubMed]
	The use of biparametric magnetic resonance imaging in active surveillance of prostate cancer. BJUI Compass Rivera López CA, Higgins MI, Jing Y, Alshak MN, Cheaib JG, Mamawala M, Landis P, Allaf ME, Macura KJ, Pavlovich CP. PMID: 42763568 [PubMed]
	Accuracy of Intraoperative Frozen Section Analysis of Sentinel Node Biopsies in Penile Cancer. Clin Genitourin Cancer Nordanger IM, Haslerud TM, Marks A, Honoré A, Thorkelsen TK, Juliebø-Jones P, Costea DE, Beisland C, Berget E, Moen CA. PMID: 42763260 [PubMed - as supplied by publisher]
	External Validation and Comparison of Magnetic Resonance Imaging-based Risk Calculators for Detection of Clinically Significant Prostate Cancer: A Multi-institutional Study Incorporating Transrectal and Transperineal Biopsy Approaches. Eur Urol Focus Zlotta AR, Taborek A, Kwong JCC, Wang A, Boulakia N, Yin LB, Zhang KK, Nguyen DD, Srigley JR, der Kwast TV, Prendeville S, Booth R, Shahid A, Ringa M, Ali A, Diamond I, Bruni S, Klotz LH, Perlis N, Fleshner N, Finelli A, Diamand R, Ghai S, Haider M, Buckley R, Feifer A, Mian BM, Kulkarni GS. PMID: 42763233 [PubMed - as supplied by publisher]
	CRISPR and Gene Editing Approaches in Prostate Cancer: Clinical Applications and Therapeutic Potential. Crit Rev Oncol Hematol Patel V, Singh P, Dutta SP, Pande S, Langstang R, Kushwaha A. PMID: 42763006 [PubMed - as supplied by publisher]
	Application of a magnetic biosensor based on novel cracker-shaped noble metal nanoparticles in dual-modal multidimensional detection of bladder cancer urinary biomarker HAase. Biosens Bioelectron Li HZ, Zhu J, Weng GJ, Li JJ, Li L, Guo YB, Zhao JW. PMID: 42762645 [PubMed - as supplied by publisher]
	TAPESTRY study: impact of prior transurethral resection of the prostate on outcomes after robot-assisted radical prostatectomy: a propensity score-matched cohort study. J Robot Surg Lenart S, Zach J, Gutjahr G, Oberhammer L, Madersbacher S, Ponholzer A, Mikulits C, Banner A. PMID: 42762391 [PubMed - indexed for MEDLINE]
	Which penile cancer patients with metastasis in a sentinel node may be spared inguinal lymph node dissection without compromising oncological safety? Development of a low-risk selection model. Int Urol Nephrol Mølsted J, Als AB, Jensen JB, Aagaard M, Jakobsen JK. PMID: 42762369 [PubMed - as supplied by publisher]
	Role of cytoreductive nephrectomy in metastatic medullary renal cell carcinoma: controlled analysis. World J Urol Le QC, Marmiroli A, Longoni M, Falkenbach F, Catanzaro C, Nicolazzini M, Polverino F, Goyal JA, Saad F, Schiavina R, Carmignani LF, Briganti A, Longo N, Graefen M, Palumbo C, Siech C, Banek S, Traumann M, Chun FK, Karakiewicz PI. PMID: 42762265 [PubMed - indexed for MEDLINE]
	Impact of one-year soy protein supplementation on serum metabolomic profiles: results from a randomized, placebo-controlled trial in prostate cancer patients. Nutr Food Sci Kato I, Emani SSB, Xu R, Yin X, Zhang X, Bosland MC, Kim S. PMID: 42762034 [PubMed]
	Development and external validation of a simple pre-biopsy risk stratification model for clinically significant prostate cancer in men with PI-RADS 3 lesions: a multicenter transperineal biopsy study. Front Oncol Peng X, Yi X, Tang S. PMID: 42761094 [PubMed]

Articles 1 - 20 / 181598

Page 1 of 9080



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy